ClinicalTrials.gg
RecruitingNCT07139379Updated Apr 15, 2026

Effects of Virtual Reality Multisensory Cooperative Task-Oriented Mirror Therapy

An interventional study of task-oriented training and Virtual Reality Mirror Therapy in Stroke, Rehabilitation and Virtual Reality, sponsored by National Cheng-Kung University Hospital. Recruiting at 1 site in Taiwan. Open to participants aged 18 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-15.

Sponsored by National Cheng-Kung University Hospital · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Jun 2025; still recruiting 1 year 4 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 19 studies in Stroke by National Cheng-Kung University Hospital — 6 open to participants now, 6 under way, 1 of them phase 3. Stroke · National Cheng-Kung University Hospital.

Planned enrollment
7th of 17
44 · median 39
Started
2025
the only one that year
No phase
15 of 19
3 open now
Registered
15th of 19
by date

Among the 19 studies in Stroke by National Cheng-Kung University Hospital, this one is the 7th largest by planned enrollment of the 17 interventional ones that give a count, is the only one that started in 2025, is one of 15 with no phase, and was the 15th registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

6 of the 19 studies in Stroke by National Cheng-Kung University Hospital are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 19 studies in Stroke by National Cheng-Kung University Hospital, or all of them as a file.
02

Study summary

In the proposed study, the investigators assumed that Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Therapy (VRMCTOMT) will provide a better treatment effects than traditional virtual reality mirror therapy (VRMT) for the patients with unilateral stroke. The aim of the study is to examine the difference in the treatment effects among the combination of task-oriented training with either VRMCTOMT, or VRMT on the upper extremity function and brain activity of the stroke patients.

03

Conditions studied

  • Stroke
  • Rehabilitation
  • Virtual Reality
  • Mirror Movement Therapy
  • Task Performance

Browse trials for

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Clinical diagnosis of stroke with unilateral side involved;
  • A score of greater than 24 for proving higher mental function
  • Time of onset > 6 months before treatment begins; and
  • Premorbid right-handedness.

Exclusion criteria

Exclusion Criteria:

  • Severe vision impairment;
  • Major cognitive-perceptual deficit;
  • Other brain disease.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Active comparator
    Virtual Reality Mirror Therapy Group

    30 minutes of task-based Virtual Reality Mirror Therapy combined with 20 minutes of conventional task-oriented therapy.

    Other: task-oriented training · Other: Virtual Reality Mirror Therapy

  • Experimental
    Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy Group

    30 minutes of Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy combined with 20 minutes of conventional task-oriented therapy.

    Other: task-oriented training · Other: Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy

Interventions

  • Othertask-oriented training

    Motor training targeted to goals that are relevant to the functional needs of the patient

  • OtherVirtual Reality Mirror Therapy

    Virtual Reality Mirror Therapy using goggle

  • OtherVirtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy

    Virtual Reality-Based Generative Bimanual Cooperative Task-Oriented Mirror Therapy using goggle

06

What researchers measure

Primary outcomes

  1. Change in the result of Fugl-Meyer assessment (FMA) for motor function of upper extremity test

    Each item is rated on a three-point ordinal scale (2 points for the detail being performed completely, 1 point for the detail being performed partially, and 0 for the detail not being performed). The maximum motor performance score is 66 points for the upper extremity.

    Time frame: baseline, 9 weeks and 21 weeks

Secondary outcomes

  1. Change in the result of Modified Ashworth scale (MAS)

    Muscle tone is defined by assess muscle tone by evaluating resistance to passive stretch, reflecting the level of spasticity, with scores ranging from 0 (no increase in tone) to 4 (rigidity in flexion or extension).

    Time frame: baseline, 9 weeks and 21 weeks

Other outcomes

  1. Change in the result of Box and blocks test

    The score is the number of blocks carried from one box to the other in one minute. Higher values represent a better outcome.

    Time frame: baseline, 9 weeks and 21 weeks

  2. Change in the result of Semmes-Weinstein monofilament (SWM) test

    The Semmes-Weinstein monofilamenttest examines the cutaneous pressure threshold, range from 1.65-6.65. Higher values represent a worse outcome.

    Time frame: baseline, 9 weeks and 21 weeks

  3. Change in the result of Motor Activity Log

    Semi-structured interview examine how much and how well the subject uses their more-affected arm for 30 ADLs. Score range from 0-5. Higher values represent a better outcome.

    Time frame: baseline, 9 weeks and 21 weeks

  4. functional Magnetic Resonance Imaging

    a non-invasive neuroimaging technique that measures brain activity by detecting changes in blood oxygenation (BOLD signal).

    Time frame: baseline, 9 weeks

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 18 months is below that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 15, 2025
First posted
Aug 24, 2025
StartActual
Jun 24, 2025
Primary completionEst.
Dec 31, 2026
CompletionEst.
Dec 31, 2026
Last update
Apr 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 15, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07139379
Responsible party
Sponsor
First posted
Aug 24, 2025
Start date
Jun 24, 2025
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Apr 15, 2026

Study contacts

Hsiu-Yun Hsu, Ph.D
Contact
hyhsu@mail.ncku.edu.tw
886-6-2353535 ext. 2669

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion